Pay in 4 interest-free payments of $6.85 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
While persistence is gradually improving, we are seeing that only a small fraction continue treatment for three years.
M., Wandless, T
Wegovy is FDA-approved for chronic weight management in individuals who are obese (patients with a BMI of 30 or greater) or overweight (BMI 27 or more) with at least one weight-related health condition
Depending on the findings, further investigations may include: Ambulatory ECG monitoring (Holter monitor or event recorder) to capture intermittent arrhythmias Echocardiography to assess cardiac structure and function Exercise stress testing if ischaemic heart disease is suspected In some cases, temporary cessation or dose reduction of testosterone therapy may be advised whilst investigations are undertaken
US$ 23.32
US$ 21.47
US$ 23.86
US$ 24.47
